Inventor · disambiguated record
Scott J. Rodig
Also filed as: RODIG SCOTT · RODIG SCOTT J
10 granted patents·3 pending applications·15 citations·filing 2008–2020
83Inventor score
Top patents by PatentIndex Score
13 records- 0183US9206427B2Compositions, kits, and methods for the modulation of immune responses using galectin-1SHIPP MARGARET A·Filed 2008·Granted Dec 8, 2015·4 cites·6 claims
- 0282US10844126B2Anti-galectin-1 (GAL1) monoclonal antibodies and fragments thereof for neutralizing GAL1DANA FARBER CANCER INST INC·Filed 2018·Granted Nov 24, 2020·1 cites·18 claims
- 0382US8968740B2Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1SHIPP MARGARET A·Filed 2010·Granted Mar 3, 2015·7 cites·14 claims
- 0476US10519238B2Anti-galectin-1 monoclonal antibodies and fragments thereofDANA FARBER CANCER INST INC·Filed 2014·Granted Dec 31, 2019·2 cites·17 claims
- 0572US11723972B2Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1DANA FARBER CANCER INST INC·Filed 2019·Granted Aug 15, 2023·0 cites·8 claims
- 0671US11673956B2Anti-galectin-1 (Gal1) monoclonal antibodies and fragments thereof for neutralizing Gal1DANA FARBER CANCER INST INC·Filed 2020·Granted Jun 13, 2023·0 cites·4 claims
- 0768US10456465B2Compositions, kits, and methods for the diagnosis prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1DANA FARBER CANCER INST INC·Filed 2015·Granted Oct 29, 2019·1 cites·22 claims
- 0856US2019212330A1Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1SHIPP MARGARET A·Filed 2018·Application pending·0 cites
- 0952US9939428B2Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1SHIPP MARGARET A·Filed 2008·Granted Apr 10, 2018·0 cites·16 claims
- 1049US2016187340A1Compositions, Kits, and Methods for the Modulation of Immune Responses Using Galectin-1DANA FARBER CANCER INST INC·Filed 2015·Application pending·0 cites
- 1143US10948492B2PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancersDANA FARBER CANCER INST INC·Filed 2016·Granted Mar 16, 2021·0 cites·21 claims
- 1243US9890429B2Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancerDANA FARBER CANCER INST INC·Filed 2013·Granted Feb 13, 2018·0 cites·20 claims
- 1333US2017029904A1Classification of myc-driven b-cell lymphomasBRIGHAM & WOMENS HOSPITAL INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott J. Rodig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →